{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:08:07Z","timestamp":1790842087934,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:00:00Z","timestamp":1612396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.xkme.2020.12.006","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T12:39:02Z","timestamp":1612960742000},"page":"267-277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Metabolic Acidosis in CKD: A Review of Recent Findings"],"prefix":"10.1016","volume":"3","author":[{"given":"Michal L.","family":"Melamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalani L.","family":"Raphael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.xkme.2020.12.006_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1053\/j.ajkd.2020.08.005","article-title":"Assessing acid-base status in patients with CKD: does measurement of blood pH matter?","volume":"77","author":"Raphael","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.xkme.2020.12.006_bib2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1053\/j.ajkd.2020.06.019","article-title":"Modulation of the association of hypobicarbonatemia and incident kidney failure with replacement therapy by venous pH: a cohort study","volume":"77","author":"Kajimoto","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.xkme.2020.12.006_bib3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1053\/j.ackd.2012.11.001","article-title":"Dietary acid load: a novel nutritional target in chronic kidney disease?","volume":"20","author":"Scialla","year":"2013","journal-title":"Adv Chronic Kidney Dis"},{"issue":"3","key":"10.1016\/j.xkme.2020.12.006_bib4","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1681\/ASN.2019070677","article-title":"Mechanisms of metabolic acidosis-induced kidney injury in chronic kidney disease","volume":"31","author":"Wesson","year":"2020","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.xkme.2020.12.006_bib5","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1681\/ASN.2014020205","article-title":"Current status of bicarbonate in CKD","volume":"26","author":"Dobre","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.xkme.2020.12.006_bib6","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1681\/ASN.2017040422","article-title":"Metabolic acidosis and subclinical metabolic acidosis in CKD","volume":"29","author":"Raphael","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.xkme.2020.12.006_bib7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1053\/j.ackd.2017.06.005","article-title":"Adverse effects of the metabolic acidosis of chronic kidney disease","volume":"24","author":"Kraut","year":"2017","journal-title":"Adv Chronic Kidney Dis"},{"issue":"6","key":"10.1016\/j.xkme.2020.12.006_bib8","first-page":"989","article-title":"Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study","volume":"32","author":"Di Iorio","year":"2019","journal-title":"J\u00a0Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2020.12.006_bib9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12916-020-01542-9","article-title":"Clinical and cost-effectiveness of oral sodium bicarbonate therapy for older patients with chronic kidney disease and low-grade acidosis (BiCARB): a pragmatic randomised, double-blind, placebo-controlled trial","volume":"18","year":"2020","journal-title":"BMC Med"},{"issue":"2","key":"10.1016\/j.xkme.2020.12.006_bib10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1053\/j.ajkd.2019.07.016","article-title":"Effects of sodium bicarbonate in CKD stages 3 and 4: a randomized, placebo-controlled, multicenter clinical trial","volume":"75","author":"Melamed","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.xkme.2020.12.006_bib11","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2215\/CJN.06600619","article-title":"Sodium bicarbonate supplementation and urinary TGF-beta1 in nonacidotic diabetic kidney disease: a randomized, controlled trial","volume":"15","author":"Raphael","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2020.12.006_bib12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1681\/ASN.2019030287","article-title":"A\u00a0randomized trial comparing the safety, adherence, and pharmacodynamics profiles of two doses of sodium bicarbonate in CKD: the BASE Pilot Trial","volume":"31","author":"Raphael","year":"2020","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"10196","key":"10.1016\/j.xkme.2020.12.006_bib13","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0140-6736(19)31388-1","article-title":"Long-term safety and efficacy of veverimer in patients with metabolic acidosis in chronic kidney disease: a multicentre, randomised, blinded, placebo-controlled, 40-week extension","volume":"394","author":"Wesson","year":"2019","journal-title":"Lancet"},{"issue":"5, pt 2","key":"10.1016\/j.xkme.2020.12.006_bib14","first-page":"F813","article-title":"Effects of in\u00a0vivo metabolic acidosis on midcortical bone ion composition","volume":"277","author":"Bushinsky","year":"1999","journal-title":"Am J Physiol"},{"issue":"3, pt 2","key":"10.1016\/j.xkme.2020.12.006_bib15","first-page":"F442","article-title":"Acidosis inhibits osteoblastic and stimulates osteoclastic activity in\u00a0vitro","volume":"262","author":"Krieger","year":"1992","journal-title":"Am J Physiol"},{"issue":"6","key":"10.1016\/j.xkme.2020.12.006_bib16","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1172\/JCI118566","article-title":"The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway","volume":"97","author":"Bailey","year":"1996","journal-title":"J\u00a0Clin Invest"},{"issue":"6 suppl 2","key":"10.1016\/j.xkme.2020.12.006_bib17","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for nutrition in chronic renal failure","volume":"35","year":"2000","journal-title":"Am J Kidney Dis"},{"issue":"2 suppl 1","key":"10.1016\/j.xkme.2020.12.006_bib18","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.xkme.2020.12.006_bib19","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/ndt\/gfn633","article-title":"Association of\u00a0serum bicarbonate levels with mortality in patients with non-dialysis-dependent CKD","volume":"24","author":"Kovesdy","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.xkme.2020.12.006_bib20","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1172\/JCI112020","article-title":"Pathophysiology of chronic tubulo-interstitial disease in rats. Interactions of dietary acid load, ammonia, and complement component C3","volume":"76","author":"Nath","year":"1985","journal-title":"J\u00a0Clin Invest"},{"issue":"10","key":"10.1016\/j.xkme.2020.12.006_bib21","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.2215\/CJN.03730411","article-title":"Serum bicarbonate and mortality in stage 3 and stage 4 chronic kidney disease","volume":"6","author":"Navaneethan","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.xkme.2020.12.006_bib22","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/ki.2010.388","article-title":"Higher serum bicarbonate levels within the normal range are associated with better survival and renal outcomes in African Americans","volume":"79","author":"Raphael","year":"2011","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.xkme.2020.12.006_bib23","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/ndt\/gfs609","article-title":"Serum bicarbonate and mortality in adults in NHANES III","volume":"28","author":"Raphael","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.xkme.2020.12.006_bib24","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1053\/j.ajkd.2009.02.014","article-title":"Serum bicarbonate levels and the progression of kidney disease: a cohort study","volume":"54","author":"Shah","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.xkme.2020.12.006_bib25","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/ndt\/gfu388","article-title":"Angiotensin II-mediated GFR decline in subtotal nephrectomy is due to acid retention associated with reduced GFR","volume":"30","author":"Wesson","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"10.1016\/j.xkme.2020.12.006_bib26","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/ki.2010.348","article-title":"Acid retention during kidney failure induces endothelin and aldosterone production which lead to progressive GFR decline, a situation ameliorated by alkali diet","volume":"78","author":"Wesson","year":"2010","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.xkme.2020.12.006_bib27","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1681\/ASN.2008111205","article-title":"Bicarbonate supplementation slows progression of CKD and improves nutritional status","volume":"20","author":"de Brito-Ashurst","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.xkme.2020.12.006_bib28","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/ki.2009.519","article-title":"Amelioration of metabolic acidosis in patients with low GFR reduced kidney endothelin production and kidney injury, and better preserved GFR","volume":"77","author":"Phisitkul","year":"2010","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.xkme.2020.12.006_bib29","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/ki.2011.313","article-title":"Dietary acid reduction with fruits and vegetables or bicarbonate attenuates kidney injury in patients with a moderately reduced glomerular filtration rate due to hypertensive nephropathy","volume":"81","author":"Goraya","year":"2012","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.xkme.2020.12.006_bib30","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2215\/CJN.02430312","article-title":"A\u00a0comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate","volume":"8","author":"Goraya","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.xkme.2020.12.006_bib31","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/ki.2014.83","article-title":"Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate","volume":"86","author":"Goraya","year":"2014","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.xkme.2020.12.006_bib32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ki.2010.129","article-title":"Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy","volume":"78","author":"Mahajan","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.xkme.2020.12.006_bib33","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"issue":"10","key":"10.1016\/j.xkme.2020.12.006_bib34","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/ki.2011.479","article-title":"Lower serum bicarbonate and a higher anion gap are associated with lower cardiorespiratory fitness in young adults","volume":"81","author":"Abramowitz","year":"2012","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.xkme.2020.12.006_bib35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1053\/j.ajkd.2010.12.021","article-title":"Association of serum bicarbonate levels with gait speed and quadriceps strength in older adults","volume":"58","author":"Abramowitz","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"10.1016\/j.xkme.2020.12.006_bib36","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.2215\/CJN.05480614","article-title":"Association of serum bicarbonate with incident functional limitation in older adults","volume":"9","author":"Yenchek","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.xkme.2020.12.006_bib37","doi-asserted-by":"crossref","first-page":"714","DOI":"10.2215\/CJN.08340812","article-title":"Effects of oral sodium bicarbonate in patients with CKD","volume":"8","author":"Abramowitz","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"13","key":"10.1016\/j.xkme.2020.12.006_bib38","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.xkme.2020.12.006_bib39","doi-asserted-by":"crossref","first-page":"e001599","DOI":"10.1161\/JAHA.114.001599","article-title":"Persistent high serum bicarbonate and the risk of heart failure in patients with chronic kidney disease (CKD): A report from the Chronic Renal Insufficiency Cohort (CRIC) study","volume":"4","author":"Dobre","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.xkme.2020.12.006_bib40","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1053\/j.ajkd.2013.01.017","article-title":"Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study","volume":"62","author":"Dobre","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"10.1016\/j.xkme.2020.12.006_bib41","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/ndt\/gfz149","article-title":"Serum bicarbonate and cardiovascular events in hypertensive adults: results from the Systolic Blood Pressure Intervention Trial","volume":"35","author":"Dobre","year":"2020","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.xkme.2020.12.006_bib42","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1053\/j.ajkd.2018.12.023","article-title":"Metabolic acidosis 1 year following kidney transplantation and subsequent cardiovascular events and mortality: an observational cohort study","volume":"73","author":"Djamali","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.xkme.2020.12.006_bib43","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.mayocp.2019.05.036","article-title":"Serum bicarbonate concentration and cause-specific mortality: the National Health and Nutrition Examination Survey 1999-2010","volume":"95","author":"Al-Kindi","year":"2020","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.xkme.2020.12.006_bib44","doi-asserted-by":"crossref","first-page":"16139","DOI":"10.1038\/s41598-019-52499-6","article-title":"Metabolic acidosis is associated with pulse wave velocity in chronic kidney disease: results from the KNOW-CKD Study","volume":"9","author":"Kim","year":"2019","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.xkme.2020.12.006_bib45","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2215\/CJN.00380118","article-title":"Effect of treatment of metabolic acidosis on vascular endothelial function in patients with CKD: a pilot randomized cross-over study","volume":"13","author":"Kendrick","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.xkme.2020.12.006_bib46","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000498975","article-title":"Oral sodium bicarbonate supplementation does not affect serum calcification propensity in patients with chronic kidney disease and chronic metabolic acidosis","volume":"44","author":"Aigner","year":"2019","journal-title":"Kidney Blood Press Res"},{"issue":"4","key":"10.1016\/j.xkme.2020.12.006_bib47","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/sj.ki.5002646","article-title":"Metabolic acidosis inhibits soft tissue calcification in uremic rats","volume":"73","author":"Mendoza","year":"2008","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.xkme.2020.12.006_bib48","first-page":"647","article-title":"Alkalinization potentiates vascular calcium deposition in an uremic milieu","volume":"22","author":"de Solis","year":"2009","journal-title":"J\u00a0Nephrol"},{"issue":"2","key":"10.1016\/j.xkme.2020.12.006_bib49","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1172\/JCI108962","article-title":"Attainment and maintenance of normal stature with alkali therapy in infants and children with classic renal tubular acidosis","volume":"61","author":"McSherry","year":"1978","journal-title":"J\u00a0Clin Invest"},{"issue":"8","key":"10.1016\/j.xkme.2020.12.006_bib50","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s00467-009-1169-y","article-title":"Bicarbonate therapy improves growth in children with incomplete distal renal tubular acidosis","volume":"24","author":"Sharma","year":"2009","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"10.1016\/j.xkme.2020.12.006_bib51","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.kint.2017.05.006","article-title":"Metabolic acidosis is common and associates with disease progression in children with chronic kidney disease","volume":"92","author":"Harambat","year":"2017","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.xkme.2020.12.006_bib52","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2215\/CJN.07060619","article-title":"Low serum bicarbonate and CKD progression in children","volume":"15","author":"Brown","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2020.12.006_bib53","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2215\/CJN.07300717","article-title":"Randomized, controlled trial of TRC101 to increase serum bicarbonate in patients with CKD","volume":"13","author":"Bushinsky","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10179","key":"10.1016\/j.xkme.2020.12.006_bib54","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(18)32562-5","article-title":"Veverimer versus placebo\u00a0in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trial","volume":"393","author":"Wesson","year":"2019","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.xkme.2020.12.006_bib55","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1681\/ASN.2016070780","article-title":"Bicarbonate balance and prescription in ESRD","volume":"28","author":"Abramowitz","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.xkme.2020.12.006_bib56","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1093\/ndt\/gfw255","article-title":"Con: higher serum bicarbonate in dialysis patients is protective","volume":"31","author":"Chauveau","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.1016\/j.xkme.2020.12.006_bib57","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/ndt\/gfw259","article-title":"Pro: higher serum bicarbonate in dialysis patients is protective","volume":"31","author":"Misra","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.xkme.2020.12.006_bib58","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0272-6386(04)00936-9","article-title":"Association of predialysis serum bicarbonate levels with risk of mortality and hospitalization in the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"44","author":"Bommer","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.xkme.2020.12.006_bib59","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2215\/CJN.00010505","article-title":"Association between serum bicarbonate\u00a0and death in hemodialysis patients: is it better to\u00a0be acidotic or alkalotic?","volume":"1","author":"Wu","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2020.12.006_bib60","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.xkme.2019.08.004","article-title":"Serum bicarbonate as a surrogate for pH in hemodialysis: a pilot study","volume":"2","author":"Woodell","year":"2020","journal-title":"Kidney Med"},{"issue":"4","key":"10.1016\/j.xkme.2020.12.006_bib61","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1053\/j.ajkd.2013.03.035","article-title":"Association of dialysate bicarbonate concentration with mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"62","author":"Tentori","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"31","key":"10.1016\/j.xkme.2020.12.006_bib62","doi-asserted-by":"crossref","first-page":"e1276","DOI":"10.1097\/MD.0000000000001276","article-title":"Low serum bicarbonate predicts residual renal function loss in peritoneal dialysis patients","volume":"94","author":"Chang","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.xkme.2020.12.006_bib63","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1159\/000479641","article-title":"Oral bicarbonate slows decline of residual renal function in peritoneal dialysis patients","volume":"42","author":"Liu","year":"2017","journal-title":"Kidney Blood Press Res"},{"issue":"8","key":"10.1016\/j.xkme.2020.12.006_bib64","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1097\/01.ASN.0000080316.37254.7A","article-title":"Oral sodium bicarbonate for the treatment of metabolic acidosis in peritoneal dialysis patients: a randomized placebo-control trial","volume":"14","author":"Szeto","year":"2003","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.xkme.2020.12.006_bib65","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/j.ajkd.2019.01.036","article-title":"Metabolic acidosis in CKD: core curriculum 2019","volume":"74","author":"Raphael","year":"2019","journal-title":"Am J Kidney Dis"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059521000194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059521000194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:21:48Z","timestamp":1762910508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059521000194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S2590059521000194"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2020.12.006","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic Acidosis in CKD: A Review of Recent Findings","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2020.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc. This is a US Government Work. There are no restrictions on its use.","name":"copyright","label":"Copyright"}]}}